Elevance Health 的投资激增，瑞穗预计上涨 17.31% 至 505 美元。 Elevance Health sees investment surge, with Mizuho predicting a 17.31% upside to $505.

高健康(NYSE: ELV)的投资兴趣增加,而CentralBook Partners和APG 资产管理公司大幅提升了它们的持有量。 Elevance Health (NYSE: ELV) has seen increased investment interest, with CenterBook Partners and APG Asset Management significantly boosting their holdings. Mizuho将其价格目标提高到505美元,表明潜在的上扬率为17.31%。 Mizuho raised its price target to $505, indicating a 17.31% potential upside. 该公司报告,最近季度的每股收益为3.84美元,略高于预期。 The company reported earnings per share (EPS) of $3.84 for the latest quarter, slightly above expectations. 提供医疗福利的Elevance Health的市值为97.45亿美元,平均"适度购买"评级为51981美元. Elevance Health, a health benefits provider, has a market cap of $97.45 billion and an average "Moderate Buy" rating with a consensus price target of $519.81.